Progress towards the Control of Strongyloidiasis in Tropical Australia?

Am J Trop Med Hyg. 2020 Feb;102(2):249-250. doi: 10.4269/ajtmh.19-0922.

Authors

Daniel L Bourque^{1

2}, Karin Leder^{3

4}

Affiliations

¹ Harvard Medical School, Boston, Massachusetts.
² Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.
³ Victorian Infectious Diseases Service, Royal Melbourne Hospital at Doherty Institute for Infection and Immunity, Melbourne, Australia.
⁴ School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

No abstract available

Publication types

Editorial

MeSH terms

Animals
Anthelmintics / therapeutic use
Australia / epidemiology
Humans
Ivermectin / therapeutic use
Strongyloides stercoralis
Strongyloidiasis / diagnosis
Strongyloidiasis / epidemiology
Strongyloidiasis / prevention & control*
Tropical Climate

Substances

Anthelmintics
Ivermectin